Patents by Inventor Deepak Phadke

Deepak Phadke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Liquid Tasimelteon Formulations and Methods of Use Thereof
    Publication number: 20260007633
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Application
    Filed: September 19, 2025
    Publication date: January 8, 2026
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Liquid tasimelteon formulations and methods of use thereof
    Patent number: 12447141
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Grant
    Filed: November 14, 2024
    Date of Patent: October 21, 2025
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20250320188
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: January 15, 2025
    Publication date: October 16, 2025
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Liquid tasimelteon formulations and methods of use thereof
    Patent number: 12440470
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Grant
    Filed: July 31, 2023
    Date of Patent: October 14, 2025
    Assignee: Vanda Pharmaceuticals Inc.
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Liquid Tasimelteon Formulations and Methods of Use Thereof
    Publication number: 20250090492
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Application
    Filed: November 14, 2024
    Publication date: March 20, 2025
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20240336584
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: June 13, 2024
    Publication date: October 10, 2024
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • MELATONIN AGONIST TREATMENT
    Publication number: 20240325339
    Abstract: Melatonin Agonist, MA-1, is administered at effective doses.
    Type: Application
    Filed: June 10, 2024
    Publication date: October 3, 2024
    Inventors: Gunther P. Birznieks, Deepak Phadke, Mihael H. Polymeropoulos
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 12049457
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: July 31, 2023
    Date of Patent: July 30, 2024
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • ILOPERIDONE METABOLITE FOR USE IN THE TREATMENT OF PSYCHIATRIC DISORDERS
    Publication number: 20240016791
    Abstract: R-P88 is used for the treatment of disorders amenable to treatment with an atypical antipsychotic.
    Type: Application
    Filed: September 26, 2023
    Publication date: January 18, 2024
    Inventors: Deepak Phadke, Curt D. Wolfgang, Mihael H. Polymeropoulos, John Joseph Feeney, Gunther Birznieks
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20230382883
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 30, 2023
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Liquid Tasimelteon Formulations and Methods of Use Thereof
    Publication number: 20230372285
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Application
    Filed: July 31, 2023
    Publication date: November 23, 2023
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Liquid tasimelteon formulations and methods of use thereof
    Patent number: 11759446
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Grant
    Filed: March 29, 2021
    Date of Patent: September 19, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 11760740
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: January 3, 2023
    Date of Patent: September 19, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20230150964
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: January 3, 2023
    Publication date: May 18, 2023
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 11566011
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: November 17, 2021
    Date of Patent: January 31, 2023
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Ophthalmic Pharmaceutical Compositions
    Publication number: 20230026577
    Abstract: The present invention provides ophthalmic pharmaceutical compositions of the compound of Formula (I).
    Type: Application
    Filed: December 4, 2020
    Publication date: January 26, 2023
    Applicant: Vanda Pharmaceuticals Inc.
    Inventors: Udaya KOTREKA, Deepak PHADKE
  • MELATONIN AGONIST TREATMENT
    Publication number: 20230021493
    Abstract: Melatonin Agonist, MA-1, is administered at effective doses.
    Type: Application
    Filed: October 14, 2022
    Publication date: January 26, 2023
    Inventors: Gunther P. Birznieks, Deepak Phadke, Mihael H. Polymeropoulos
  • HIGHLY PURIFIED PHARMACEUTICAL GRADE TASIMELTEON
    Publication number: 20220073482
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Application
    Filed: November 17, 2021
    Publication date: March 10, 2022
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada
  • Liquid tasimelteon formulations and methods of use thereof
    Patent number: 11202770
    Abstract: Liquid suspensions of tasimelteon and methods for their use.
    Type: Grant
    Filed: December 11, 2020
    Date of Patent: December 21, 2021
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Mihael Polymeropoulos
  • Highly purified pharmaceutical grade tasimelteon
    Patent number: 11203581
    Abstract: A process for preparing a batch of highly purified, pharmaceutical grade tasimelteon comprises analyzing a batch of tasimelteon synthesized under GMP conditions for the presence of one or more identified impurities.
    Type: Grant
    Filed: September 30, 2020
    Date of Patent: December 21, 2021
    Assignee: VANDA PHARMACEUTICALS INC.
    Inventors: Deepak Phadke, Natalie M. Platt, Ravi K. Pandrapragada